Revisiting Daclizumab for Multiple Sclerosis: A Systematic Evaluation of a Targeted Immunotherapy.

Naghdi Y, Azhari Rad R, Keshavarzian M, Yousefi Z, Shams MH, Jafari R

DOI: 10.1080/08923973.2026.2761417
Published: 2026 Nov 8
Container: Immunopharmacology and immunotoxicology
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1080/08923973.2026.2761417,
  title = {Revisiting Daclizumab for Multiple Sclerosis: A Systematic Evaluation of a Targeted Immunotherapy.},
  author = {Naghdi Y and Azhari Rad R and Keshavarzian M and Yousefi Z and Shams MH and Jafari R},
  year = {2026},
  journal = {Immunopharmacology and immunotoxicology},
  doi = {10.1080/08923973.2026.2761417},
  url = {https://doi.org/10.1080/08923973.2026.2761417}
}

RIS

TY  - JOUR
TI  - Revisiting Daclizumab for Multiple Sclerosis: A Systematic Evaluation of a Targeted Immunotherapy.
AU  - Naghdi Y
AU  - Azhari Rad R
AU  - Keshavarzian M
AU  - Yousefi Z
AU  - Shams MH
AU  - Jafari R
PY  - 2026
JO  - Immunopharmacology and immunotoxicology
DO  - 10.1080/08923973.2026.2761417
UR  - https://doi.org/10.1080/08923973.2026.2761417
ER  -

APA

Y, N., R, A. R., M, K., Z, Y., MH, S., & R, J. (2026). Revisiting Daclizumab for Multiple Sclerosis: A Systematic Evaluation of a Targeted Immunotherapy.. Immunopharmacology and immunotoxicology. https://doi.org/10.1080/08923973.2026.2761417

Source records

pubmed · retrieved 2026-11-10T14:29:16.130Z